A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

被引：1
|
作者：
Rovithi, Maria
Labots, Marlette
Richard
Honeywell
Ten Tije, Albert J.
Ruijter, Rita
Skardhamar, Mikkjal
Peters, Godefridus J.
Voortman, Jens
Verheul, Henk M. W.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2591
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：5
相关论文
共 50 条
  • [31] A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
    Fury, Matthew G.
    Solit, David B.
    Su, Yungpo Bernard
    Rosen, Neal
    Sirotnak, F. M.
    Smith, Robert P.
    Azzoli, Christopher G.
    Gomez, Jorge E.
    Miller, Vincent A.
    Kris, Mark G.
    Pizzo, Barbara A.
    Henry, Roxanne
    Pfister, David G.
    Rizvi, Naiyer A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (04) : 467 - 475
  • [32] A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
    Matthew G. Fury
    David B. Solit
    Yungpo Bernard Su
    Neal Rosen
    F. M. Sirotnak
    Robert P. Smith
    Christopher G. Azzoli
    Jorge E. Gomez
    Vincent A. Miller
    Mark G. Kris
    Barbara A. Pizzo
    Roxanne Henry
    David G. Pfister
    Naiyer A. Rizvi
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 467 - 475
  • [33] A QTc study of cabazitaxel in patients with advanced solid tumors.
    Wade, James Lloyd
    Dakhil, Shaker R.
    Baron, Ari David
    Rottey, Sylvie
    Millard, Frederick E.
    Daugaard, Gedske
    Machiels, Jean-Pascal H.
    Conkright, William A.
    Sharma, Sunil
    Soetekouw, Patricia M. M. B.
    Yachnin, Jeffrey
    Sengelov, Lisa
    van Veldhuizen, Peter
    Agarwala, Sanjiv S.
    Nguyen, T. X. Quyen
    Chadjaa, Mustapha
    Maison-Blanche, Pierre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] A phase 1 dose-escalation and -expansion study of IMP7068, a WEE1 inhibitor, in patients with advanced solid tumors.
    Lin, Chia-Chi
    Grewal, Jaspreet Singh
    Sommerhalder, David
    Strauss, James Fredric
    Bai, Li-Yuan
    Shen, Lin
    Yeh, Yu-Min
    Hsieh, Chih-Yi
    Cai, Sui Xiong
    Tian, Ye Edward
    Xia, Huan
    Zhang, Congcong
    Li, Baoyue
    Zhang, Ming
    Ma, Ning
    Zhao, Liping
    Ma, Jie
    Shi, Huiyan
    Yu, Zhixin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] High-Dose Intermittent Treatment with the Multikinase Inhibitor Sunitinib Leads to High Intra-Tumor Drug Exposure in Patients with Advanced Solid Tumors
    Gerritse, Sophie L.
    Labots, Mariette
    Ter Heine, Rob
    Dekker, Henk
    Poel, Dennis
    Tauriello, Daniele V. F.
    Nagtegaal, Iris D.
    van den Hombergh, Erik
    Van Erp, Nielka
    Verheul, Henk M. W.
    CANCERS, 2022, 14 (24)
  • [36] A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors.
    Matulonis, Ursula A.
    Janku, Filip
    Moser, Justin C.
    Fu, Siqing
    Wages, David S.
    Wheeler, Catherine A.
    Mori, Mikinaga
    Shimoyama, Susumu
    Yamada, Naoki
    Subach, Ruth Ann
    Cheung, Kin
    Madden, Timothy
    Maier, Gary
    Johansen, Mary
    Falchook, Gerald Steven
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [37] Phase 1 study of an oxidative phosphorylation inhibitor IM156 in patients with advanced solid tumors.
    Rha, Sun Young
    Beom, Seung-Hoon
    Jung, Minkyu
    Shin, Young Geun
    Cheong, Jae-Ho
    Kim, Hyo Song
    Kim, Gun Min
    Chang, Jong Hee
    Lee, Young Woo
    Chong, Yunseon
    Yoo, Sanghee
    O'Neil, Vincent
    Janku, Filip
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] First-in-human phase 1 study of DS-1062a in patients with advanced solid tumors.
    Sands, Jacob M.
    Shimizu, Toshio
    Garon, Edward B.
    Greenberg, Jonathan
    Guevara, Ferdinand M.
    Heist, Rebecca Suk
    Kobayashi, Fumiaki
    Noguchi, Yutaka
    Okajima, Daisuke
    Tajima, Naoyuki
    Spira, Alexander I.
    Yamamoto, Noboru
    Lisberg, Aaron Elliott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Phase I study of regorafenib and sildenafil in advanced solid tumors.
    Poklepovic, Andrew Stewart
    Gordon, Sarah W.
    McGuire, William P.
    Thacker, Leroy R.
    Deng, Xiaoyan
    Tombes, Mary Beth
    Shrader, Ellen
    Ryan, Alison A.
    Kmieciak, Maciej
    Dent, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345